SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-15-025654
Filing Date
2015-01-29
Accepted
2015-01-29 16:31:50
Documents
3
Effectiveness Date
2015-01-29

Document Format Files

Seq Description Document Type Size
1 S-8 d859760ds8.htm S-8 56190
2 EX-5.1 d859760dex51.htm EX-5.1 4138
3 EX-23.2 d859760dex232.htm EX-23.2 1447
  Complete submission text file 0001193125-15-025654.txt   62804
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-201754 | Film No.: 15559280
SIC: 2834 Pharmaceutical Preparations